Achmea Investment Management B.V. Increases Position in Aflac Incorporated (NYSE:AFL)

Achmea Investment Management B.V. increased its position in Aflac Incorporated (NYSE:AFL - Free Report) by 2.2% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 302,150 shares of the financial services provider's stock after buying an additional 6,504 shares during the period. Achmea Investment Management B.V. owned about 0.06% of Aflac worth $33,596,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of AFL. Whipplewood Advisors LLC purchased a new position in Aflac in the 4th quarter worth approximately $26,000. Curio Wealth LLC purchased a new position in Aflac during the fourth quarter valued at $36,000. Garde Capital Inc. bought a new stake in Aflac in the 1st quarter valued at $36,000. OFI Invest Asset Management purchased a new stake in Aflac in the 4th quarter worth $38,000. Finally, Capital A Wealth Management LLC bought a new position in shares of Aflac during the 4th quarter valued at about $38,000. 67.44% of the stock is owned by institutional investors.

Aflac Price Performance

Shares of NYSE AFL opened at $104.00 on Friday. The company has a market cap of $56.23 billion, a PE ratio of 16.25, a P/E/G ratio of 3.17 and a beta of 0.82. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.09 and a current ratio of 0.09. The business has a 50-day simple moving average of $104.60 and a two-hundred day simple moving average of $105.19. Aflac Incorporated has a fifty-two week low of $88.00 and a fifty-two week high of $115.50.

Aflac (NYSE:AFL - Get Free Report) last posted its quarterly earnings data on Wednesday, April 30th. The financial services provider reported $1.66 EPS for the quarter, missing the consensus estimate of $1.67 by ($0.01). The company had revenue of $3.40 billion for the quarter, compared to analyst estimates of $4.53 billion. Aflac had a return on equity of 15.55% and a net margin of 21.27%. The company's quarterly revenue was down 37.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.66 earnings per share. As a group, equities analysts expect that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Aflac Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, June 2nd. Investors of record on Wednesday, May 21st were issued a $0.58 dividend. The ex-dividend date of this dividend was Wednesday, May 21st. This represents a $2.32 annualized dividend and a yield of 2.23%. Aflac's dividend payout ratio (DPR) is presently 36.25%.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on AFL. Raymond James Financial cut their price target on Aflac from $115.00 to $110.00 and set an "outperform" rating for the company in a report on Thursday, May 29th. Morgan Stanley boosted their price objective on shares of Aflac from $100.00 to $105.00 and gave the company an "equal weight" rating in a research report on Monday, May 19th. Wall Street Zen lowered Aflac from a "hold" rating to a "sell" rating in a research report on Monday, May 5th. Barclays increased their target price on Aflac from $95.00 to $96.00 and gave the stock an "underweight" rating in a research note on Thursday, May 1st. Finally, Keefe, Bruyette & Woods increased their price objective on Aflac from $104.00 to $106.00 and gave the stock a "market perform" rating in a research note on Wednesday, May 7th. Three analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $104.93.

Insiders Place Their Bets

In related news, Director Arthur Reginald Collins sold 2,750 shares of the firm's stock in a transaction dated Thursday, May 15th. The stock was sold at an average price of $105.70, for a total transaction of $290,675.00. Following the sale, the director now directly owns 6,728 shares of the company's stock, valued at $711,149.60. This trade represents a 29.01% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Masatoshi Koide sold 37,000 shares of the business's stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $105.59, for a total value of $3,906,830.00. Following the completion of the transaction, the director now directly owns 70,992 shares of the company's stock, valued at $7,496,045.28. The trade was a 34.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 40,750 shares of company stock valued at $4,304,295. 0.90% of the stock is owned by insiders.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.